Alisje Churchyard
London, ENG SW72AZ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Structure-Guided Optimization of Novel Inhibitors of Plasmodium Lysyl-tRNA Synthetase with Multistage Activity against Malaria Parasites.
Journal: Journal of medicinal chemistry
Published: June 02, 2026
Evaluation of Malaria Parasite Transmission Competency Using a Nanozyme-Based Immunodiagnostic Targeting Female Gamete Antigen Release.
Journal: ACS nano
Published: October 06, 2025
Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4.
Journal: Journal of medicinal chemistry
Published: April 14, 2025
Exploration and characterization of the antimalarial activity of cyclopropyl carboxamides that target the mitochondrial protein, cytochrome b.
Journal: European journal of medicinal chemistry
Published: September 03, 2024
7-N-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome bc1 Complex.
Journal: ACS infectious diseases
Published: February 28, 2023
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4.
Journal: Journal of medicinal chemistry
Published: February 22, 2023
Fast-Killing Tyrosine Amide ((S)-SW228703) with Blood- and Liver-Stage Antimalarial Activity Associated with the Cyclic Amine Resistance Locus (PfCARL).
Journal: ACS infectious diseases
Published: February 10, 2023
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy.
Journal: Science (New York, N.Y.)
Published: June 02, 2022
Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 16, 2021
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183.
Journal: Nature communications
Published: May 17, 2021
Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as Plasmodium Cytoplasmic Prolyl-tRNA Synthetase Inhibitors.
Journal: ACS infectious diseases
Published: April 30, 2021
Last Updated: 09/26/2026